Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
Nanotheranostics
|
January 3, 2022
Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis
Kristen R Hollinger, Anjali Sharma, Carolyn Tallon, et al.
Journal of Medicinal Chemistry
|
April 17, 2020
Novel Human Neutral Sphingomyelinase 2 Inhibitors as Potential Therapeutics for Alzheimer's Disease
Michal Šála, Kristen R Hollinger, Ajit G Thomas, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 27, 2025
Inhibition of microglial glutaminase alleviates chronic stress-induced neurobehavioral and cognitive deficits
Meixiang Huang, Yannan Li, Ajit G Thomas, et al.
Pharmaceutics
|
October 27, 2022
Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice
Carolyn Tallon, Benjamin J Bell, Anjali Sharma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 14, 2019
Correction: JHU-083 selectively blocks glutaminase activity in brain CD11b<sup>+</sup> cells and prevents depression-associated behaviors induced by chronic social defeat stress
Xiaolei Zhu, Michael T Nedelcovych, Ajit G Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 22, 2018
JHU-083 selectively blocks glutaminase activity in brain CD11b<sup>+</sup> cells and prevents depression-associated behaviors induced by chronic social defeat stress
Xiaolei Zhu, Michael T Nedelcovych, Ajit G Thomas, et al.
Molecular Pharmaceutics
|
August 2, 2017
Enhanced Brain Delivery of 2-(Phosphonomethyl)pentanedioic Acid Following Intranasal Administration of Its γ-Substituted Ester Prodrugs
Michael Nedelcovych, Ranjeet P Dash, Lukáš Tenora, et al.
Proteomics
|
June 25, 2019
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
Sunag Udupa, Stephanie Nguyen, Giang Hoang, et al.
Frontiers in Pharmacology
|
October 31, 2025
Mass spectrometry-guided discovery of novel GCPII inhibitor scaffolds
Robyn Wiseman, Ajit G Thomas, John Janiszewski, et al.
Research Square
|
July 28, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer's disease
Carolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
Nanotheranostics
|
January 3, 2022
Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis
Kristen R Hollinger, Anjali Sharma, Carolyn Tallon, et al.
Journal of Medicinal Chemistry
|
April 17, 2020
Novel Human Neutral Sphingomyelinase 2 Inhibitors as Potential Therapeutics for Alzheimer's Disease
Michal Šála, Kristen R Hollinger, Ajit G Thomas, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 27, 2025
Inhibition of microglial glutaminase alleviates chronic stress-induced neurobehavioral and cognitive deficits
Meixiang Huang, Yannan Li, Ajit G Thomas, et al.
Pharmaceutics
|
October 27, 2022
Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice
Carolyn Tallon, Benjamin J Bell, Anjali Sharma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 14, 2019
Correction: JHU-083 selectively blocks glutaminase activity in brain CD11b<sup>+</sup> cells and prevents depression-associated behaviors induced by chronic social defeat stress
Xiaolei Zhu, Michael T Nedelcovych, Ajit G Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 22, 2018
JHU-083 selectively blocks glutaminase activity in brain CD11b<sup>+</sup> cells and prevents depression-associated behaviors induced by chronic social defeat stress
Xiaolei Zhu, Michael T Nedelcovych, Ajit G Thomas, et al.
Molecular Pharmaceutics
|
August 2, 2017
Enhanced Brain Delivery of 2-(Phosphonomethyl)pentanedioic Acid Following Intranasal Administration of Its γ-Substituted Ester Prodrugs
Michael Nedelcovych, Ranjeet P Dash, Lukáš Tenora, et al.
Proteomics
|
June 25, 2019
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
Sunag Udupa, Stephanie Nguyen, Giang Hoang, et al.
Frontiers in Pharmacology
|
October 31, 2025
Mass spectrometry-guided discovery of novel GCPII inhibitor scaffolds
Robyn Wiseman, Ajit G Thomas, John Janiszewski, et al.
Research Square
|
July 28, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer's disease
Carolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Page
of 8